FDA and the life-sciences industry: Business as usual?

Hastings Center Report

Volumn 34, Issue 5, 2004, Pages 24-27

  Koski, Greg ^a,b,c  

^a Off for Human Research Protections   (United States)

^b Massachusetts General Hospital ^*

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

BIOMEDICINE; DRUG INDUSTRY; DRUG SAFETY; DRUG SCREENING; ETHICS; FOOD AND DRUG ADMINISTRATION; HUMAN; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; SUICIDAL BEHAVIOR; ADULT; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CHILD; HEALTH CARE AND PUBLIC HEALTH; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; POLITICS; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH;

ADULT; ANTIDEPRESSIVE AGENTS; CHILD; DRUG INDUSTRY; HUMANS; POLITICS; TRUTH DISCLOSURE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 14644409292     PISSN: 00930334     EISSN: None     Source Type: Journal    
DOI: 10.2307/3527587     Document Type: Review

References (13)

1. A.K. Sachkev, letter to Representative Joe Barton, April 14, 2004; available at http://energycommerce.house.gov/108/News/ FDAResponseonAntidepressants.pdf.
2. G. Harris, "Anti depressant Study Seen to Back Expert," New York Times, August 20, 2004.
3. House Committee on Energy and Commerce, "FDA Responds to Barton, Greenwood Inquiry on Antidepressant Use," press release, April 15, 2004; available at http://energycommerce.house.gov/108/News/04152004_1251.htm.
4. http://energycommerce.house.gov/108/letters/03242004_1242.htm.
5. To get a sense of how profitable, see Public Citizen Congress Watch, "Drug Industry Profits: Hefty Pharmaceutical Company Margins Dwarf Other Industries," June 2003 http://www.citizen.org/documents/Pharma_Report.pdf.
6. Public Citizen, "The Other Drug War: Big Pharma's 625 Washington Lobbyists"; available at http://www.citizen.org/congress/campaign/ special_interest/articles.cfm?ID=6537.
7. D. Cauchon, "FDA Advisers Tied to Industry," USA Today, September 25, 2000; and D. Cauchon, "Number of Drug Experts Available Is Limited," USA Today, September 25, 2000.
8. D. Cauchon, "FDA Advisers Tied to Industry," USA Today, September 25, 2000; and D. Cauchon, "Number of Drug Experts Available Is Limited," USA Today, September 25, 2000.
9. D. William, "Steal and Merge: Drug Comanies and Government Research" Los Angeles Times, December 7, 2003.
10. http://www.nytimes.com/2004/07/25/politics/25DRUG.html?ex= 1094011200&en=2dc0cbea8c71daf8&ei=5070&hp, The New York Times, July 25, 2004.
11. The Harris Poll, "Reputations of Pharmaceutical and Health Insurance Companies Continue Their Downward Slide," Health Care News 4, no 11 (2004); available at http://www.harrisinteractive.com/news/newsletters/ healthnews/HI_HealthCareNews2004Vol4_Iss11.pdf
12. W. Alexander et al., European Molecular Biology Organization Reports, 5 (2004).
13. For information on "The Institute for One-World Health," see http://www.oneworldhealth.org.